Your browser doesn't support javascript.
loading
Impact of regulatory interventions to restrict the combined use of renin-angiotensin system blockers: A Danish nationwide drug utilisation study.
Sindahl, Per; Ofori-Asenso, Richard; Hallgreen, Christine Erikstrup; Kemp, Kaare; Gardarsdottir, Helga; De Bruin, Marie Louise.
Afiliación
  • Sindahl P; Division of Pharmacovigilance and Medical Devices, Danish Medicines Agency, Copenhagen, Denmark.
  • Ofori-Asenso R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
  • Hallgreen CE; Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kemp K; Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Gardarsdottir H; Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • De Bruin ML; Division of Pharmacovigilance and Medical Devices, Danish Medicines Agency, Copenhagen, Denmark.
Br J Clin Pharmacol ; 88(3): 1379-1384, 2022 03.
Article en En | MEDLINE | ID: mdl-34519065

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Hipertensión Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Hipertensión Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca